Preparation of functionally preserved CD4+ CD25high regulatory T cells from leukapheresis products from ulcerative colitis patients, applicable to regulatory T-cell transfer therapy

By Sumida Y.   Nakamura K.   Kanayama K.   Akiho H.   Teshima T.   Takayanagi R.  

Cytotherapy, Vol. 10, Iss. 7, 2008-01 ,pp. : 698-710

Ashgate Publishing Ltd

Access to resources Recommend Favorite

Rapamycin enriches for CD4+ CD25+ CD27+ Foxp3+ regulatory T cells in ex vivo-expanded CD25-enriched products from healthy donors and patients with multiple sclerosis

By Keever-Taylor Ca   Browning Mb   Johnson Bd   Truitt Rl   Bredeson Cn   Behn B.   Tsao A.  

Cytotherapy, Vol. 9, Iss. 2, 2007-01 ,pp. : 144-157

Ashgate Publishing Ltd

Access to resources Recommend Favorite

Validation of a formula for predicting daily CD34⁺⁺ cell collection by leukapheresis

By Rosenbaum Eric R.   O'connell Bernadette   Cottler-Fox Michele  

Cytotherapy, Vol. 14, Iss. 4, 2012-04 ,pp. : 461-466

Ashgate Publishing Ltd

Access to resources Recommend Favorite

A comparison of CFU-GM, BFU-E and endothelial progenitor cells using ex vivo expansion of selected cord blood CD133+ and CD34+ cells

By Lu X.   Baudouin SV   Gillespie JI   Anderson JJ   Dickinson AM  

Cytotherapy, Vol. 9, Iss. 3, 2007-01 ,pp. : 292-300

Ashgate Publishing Ltd

Access to resources Recommend Favorite

Selection of CD34⁺ Cells from Cryopreserved PBPC can be Significantly Improved by the Addition of Recombinant Human DNase (Pulmozyme)

By Alcorn MJ   Richmond LJ   Farrell E   Barr J   Pearson C   Schupp R   Franklin IM  

Cytotherapy, Vol. 1, Iss. 1, 1999-01 ,pp. : 31-40

Ashgate Publishing Ltd

Access to resources Recommend Favorite